CN1259422C - 呼吸合胞病毒的吸附(g)蛋白衍生的肽 - Google Patents

呼吸合胞病毒的吸附(g)蛋白衍生的肽 Download PDF

Info

Publication number
CN1259422C
CN1259422C CNB988104911A CN98810491A CN1259422C CN 1259422 C CN1259422 C CN 1259422C CN B988104911 A CNB988104911 A CN B988104911A CN 98810491 A CN98810491 A CN 98810491A CN 1259422 C CN1259422 C CN 1259422C
Authority
CN
China
Prior art keywords
protein
rsv
peptide
altered
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988104911A
Other languages
English (en)
Chinese (zh)
Other versions
CN1322250A (zh
Inventor
G·E·汉考克
P·W·特伯贝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CN1322250A publication Critical patent/CN1322250A/zh
Application granted granted Critical
Publication of CN1259422C publication Critical patent/CN1259422C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNB988104911A 1997-09-19 1998-09-17 呼吸合胞病毒的吸附(g)蛋白衍生的肽 Expired - Fee Related CN1259422C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5968497P 1997-09-19 1997-09-19
US60/059,684 1997-09-19
US8486398P 1998-05-08 1998-05-08
US60/084,863 1998-05-08

Publications (2)

Publication Number Publication Date
CN1322250A CN1322250A (zh) 2001-11-14
CN1259422C true CN1259422C (zh) 2006-06-14

Family

ID=26739056

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988104911A Expired - Fee Related CN1259422C (zh) 1997-09-19 1998-09-17 呼吸合胞病毒的吸附(g)蛋白衍生的肽

Country Status (13)

Country Link
EP (1) EP1015595B1 (enExample)
JP (1) JP2001516583A (enExample)
KR (1) KR100550132B1 (enExample)
CN (1) CN1259422C (enExample)
AT (1) ATE287957T1 (enExample)
AU (1) AU751022B2 (enExample)
BR (1) BR9812240A (enExample)
CA (1) CA2302833C (enExample)
CY (1) CY1105010T1 (enExample)
DE (1) DE69828801T2 (enExample)
ES (1) ES2236946T3 (enExample)
PT (1) PT1015595E (enExample)
WO (1) WO1999014334A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1334119B2 (en) 2000-10-18 2018-11-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Compositions and methods for modulating rsv infection and immunity
AUPR520201A0 (en) * 2001-05-23 2001-06-14 Commonwealth Scientific And Industrial Research Organisation Antiviral compounds
NL1019228C1 (nl) 2001-10-25 2003-04-28 Duynstee Holding B V Verbeterd gecombineerd ophang- en verlichtingssysteem voor bijvoorbeeld schilderijen e.d.
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
DE10219219A1 (de) 2002-04-29 2003-11-06 Tampoflex Gmbh Druckanlage
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides
US7368537B2 (en) * 2003-07-15 2008-05-06 Id Biomedical Corporation Of Quebec Subunit vaccine against respiratory syncytial virus infection
RU2006117366A (ru) 2003-10-23 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные бензазепина в качестве ингибиторов мао-в
US7666433B2 (en) * 2004-06-30 2010-02-23 Wyeth Holdings Corporation Recombinant RSV strains with altered G protein
EP2181121A4 (en) * 2007-03-21 2012-07-11 Id Biomedical Corp Quebec CHIMÄRE ANTIGENE
US8563002B2 (en) 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
SG176807A1 (en) 2009-06-24 2012-01-30 Id Biomedical Corp Quebec Vaccine
PL2445526T3 (pl) 2009-06-24 2017-08-31 Glaxosmithkline Biologicals S.A. Rekombinowane antygeny rsv
EP4183412B1 (en) 2009-07-15 2024-08-14 GlaxoSmithKline Biologicals SA Rsv f protein compositions and methods for making same
EP2453903B1 (en) * 2009-07-17 2016-08-17 Industry Academic Cooperation Foundation, Hallym University Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
US8846056B2 (en) 2009-08-04 2014-09-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control Anti-RSV immunogens and methods of immunization
RS56748B1 (sr) 2011-05-13 2018-03-30 Glaxosmithkline Biologicals Sa Pre-fuzioni rsv f antigeni
EP3956351A1 (en) * 2019-04-18 2022-02-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Biological and synthetic molecules inhibiting respiratory syncytial virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
AU722494C (en) * 1996-06-05 2007-03-29 Commonwealth Scientific And Industrial Research Organisation Viral peptides with structural homology to protein G of respiratory syncytial virus
AUPO026596A0 (en) * 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide

Also Published As

Publication number Publication date
DE69828801D1 (de) 2005-03-03
AU9572598A (en) 1999-04-05
KR100550132B1 (ko) 2006-02-08
CA2302833C (en) 2007-05-08
JP2001516583A (ja) 2001-10-02
WO1999014334A1 (en) 1999-03-25
CN1322250A (zh) 2001-11-14
KR20010030620A (ko) 2001-04-16
BR9812240A (pt) 2000-07-18
DE69828801T2 (de) 2005-07-14
CA2302833A1 (en) 1999-03-25
PT1015595E (pt) 2005-05-31
AU751022B2 (en) 2002-08-08
ES2236946T3 (es) 2005-07-16
CY1105010T1 (el) 2010-03-03
EP1015595A1 (en) 2000-07-05
EP1015595B1 (en) 2005-01-26
ATE287957T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
CN1229501C (zh) Hiv多包膜蛋白疫苗的重组痘苗载体混合物
CN1197618C (zh) 突变霍乱全毒素佐剂
CN1188519C (zh) 包含HIV－1Tat和/或Nef蛋白的融合蛋白
CN1201818C (zh) 疫苗
CN1183968C (zh) 改良疫苗
CN1285608C (zh) 副流感病毒糖蛋白和疫苗
CN1606624A (zh) 疫苗
CN1835767A (zh) 对抗支气管败血性博德特氏杆菌的犬疫苗
CN101035558A (zh) 对抗布拉迪斯拉发钩端螺旋体和其他病原体的多价犬疫苗
EP1015595B1 (en) Peptides derived from the attachment (g) protein of respiratory syncytial virus
CN1281748C (zh) 为改善IL－12活性而突变的IL－12p40亚基基因及其作为DNA疫苗佐剂的用途
CN1192799C (zh) 佐剂组合制剂
CN1355846A (zh) 用于下调节白细胞介素5活性的方法
CN1158387C (zh) 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因
CN1705492A (zh) 用于诱发抗过敏原保护性免疫应答的重组核酸
CN1741818A (zh) 线虫多肽佐剂
CN1639569A (zh) 诱导免疫应答的方法和组合物
CN1812810A (zh) 针对fiv感染的免疫接种材料和方法
CN1656116A (zh) 包含hpv－16病毒的突变e7蛋白的非免疫抑制免疫原性组合物或疫苗组合物
CN1495262A (zh) gp350/220的非剪接变异体
CN101048178A (zh) 作为疫苗的重组分枝杆菌和生物活性剂的组合
CN1922309A (zh) 具有反式互补的基因组缺陷的呼吸道合胞病毒
CN101039955A (zh) 与sars冠状病毒刺突蛋白相关的核酸、多肽、表达方法和免疫原性组合物
CN1531548A (zh) 编码可诱导抗病毒效应的蛋白质的嵌合链
US6699478B1 (en) Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee